| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5304 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2767 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1663 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1333 | 2021 |
| Imperfect vaccination can enhance the transmission of highly virulent pathogens AF Read, SJ Baigent, C Powers, LB Kgosana, L Blackwell, LP Smith, ... PLoS biology 13 (7), e1002198, 2015 | 404 | 2015 |
| Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison M Ainsworth, M Andersson, K Auckland, JK Baillie, E Barnes, S Beer, ... The Lancet Infectious Diseases 20 (12), 1390-1400, 2020 | 316 | 2020 |
| Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ... The Lancet 398 (10304), 981-990, 2021 | 270 | 2021 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, B Angus, MA Ansari, ... Cell 185 (5), 916-938. e58, 2022 | 160 | 2022 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 137 | 2020 |
| Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic British Journal of Surgery 108 (1), 88-96, 2021 | 83 | 2021 |
| Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic COVIDSurg Collaborative, JC Glasbey, D Nepogodiev, JFF Simoes, ... Colorectal Disease 23 (3), 732-749, 2021 | 65 | 2021 |
| Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model MM Gibani, E Jones, A Barton, C Jin, J Meek, S Camara, U Galal, E Heinz, ... Nature medicine 25 (7), 1082-1088, 2019 | 55 | 2019 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 30 | 2022 |
| Divergent trajectories of antiviral memory after SARS-CoV-2 infection A Tomic, DT Skelly, A Ogbe, D O’Connor, M Pace, E Adland, F Alexander, ... Nature Communications 13 (1), 1251, 2022 | 27 | 2022 |
| Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model MM Gibani, C Jin, S Shrestha, M Moore, L Norman, M Voysey, E Jones, ... PLOS Neglected Tropical Diseases 14 (10), e0008783, 2020 | 23 | 2020 |
| Diagnostic host gene signature for distinguishing enteric fever from other febrile diseases CJ Blohmke, J Muller, MM Gibani, H Dobinson, S Shrestha, ... EMBO Molecular Medicine 11 (10), e10431, 2019 | 17 | 2019 |
| Presumed risk factors and biomarkers for severe respiratory syncytial virus disease and related sequelae: protocol for an observational multicenter, case-control study from the … K Jefferies, SB Drysdale, H Robinson, EA Clutterbuck, L Blackwell, ... The Journal of infectious diseases 222 (Supplement_7), S658-S665, 2020 | 9 | 2020 |
| Molecular correlates of vaccine-induced protection against typhoid fever H Zhu, I Chelysheva, DL Cross, L Blackwell, C Jin, MM Gibani, E Jones, ... The Journal of Clinical Investigation 133 (16), 2023 | 4 | 2023 |
| Immunisation with purified Coxiella burnetii phase I lipopolysaccharide confers partial protection in mice independently of co-administered adenovirus vectored vaccines C Dold, H Zhu, L Silva-Reyes, L Blackwell, A Linder, K Bewley, K Godwin, ... Vaccine 41 (19), 3047-3057, 2023 | 3 | 2023 |
| Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation CS Rollier, C Dold, L Blackwell, A Linder, L Silva-Reyes, E Clutterbuck, ... Vaccine 40 (32), 4453-4463, 2022 | 2 | 2022 |
